insights_auto
Why is GANX up 25.51%?
Dive Deeperchevron_right
GANX:NASDAQ
Gain Therapeutics Inc
US$1.18
arrow_upward
+25.51%(+0.24) 1D
US$1.20
arrow_upward
+1.69% (+0.020)bedtimeAfter hours
Closed: ኖቬም 17, 4:00:01 ከሰዓት ጂ ኤም ቲ-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GANX...
Open
US$0.98
High
US$1.30
Low
US$0.97
Mkt. cap
52.55 ሚ
Avg. vol.
536.00 ሺ
Volume
4.23 ሚ
52-wk high
US$4.34
52-wk low
US$0.94
EPS
-US$0.43
Beta
0.29
Shares outstanding
44.52 ሚ
No. of employees
21
Open
US$0.98
High
US$1.30
Low
US$0.97
Mkt. cap
52.55 ሚ
Avg. vol.
536.00 ሺ
Volume
4.23 ሚ
52-wk high
US$4.34
52-wk low
US$0.94
EPS
-US$0.43
Beta
0.29
Shares outstanding
44.52 ሚ
No. of employees
21
News stories
From web sources and news partners
Investing.com Canada
·
ከ1 ደቂቃ በፊት
Gain Therapeutics reports 12-month rexaceract trial results By Investing.com
kalkine.ca
·
ከ3 ሰዓቶች በፊት
Why Are Gain Therapeutics (NASDAQ:GANX) Shares Up 23.38% When No Company News Has Surfaced?
Benzinga
·
ከ4 ሰዓቶች በፊት
12 Health Care Stocks Moving In Tuesday's Intraday Session
About Gain Therapeutics Inc
CEO-
Employees21
Founded2017
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitegaintherapeutics.com